https://endpts.com/pfizer-ceo-points-to-ira-as-a-factor-that-made-seagen-an-attractive-target/
0
0
3/13/23 at 11:27am
Organization
Endpoints News
Author
Zachary Brennan
60 words
0
Comments
One of the reasons Pfizer sought to purchase Seagen, as part of a $43 billion deal announced this morning, is that the Seattle-based biotech will be able to withstand the coming headwinds of the Inflation Reduction Act and the Medicare price negotiations that…
You are the first to view
Create an account
or login to join the discussion